ProfileGDS4718 / 225984_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 87% 88% 83% 86% 90% 81% 87% 87% 86% 89% 91% 88% 85% 82% 84% 88% 89% 88% 80% 79% 86% 87% 88% 87% 89% 86% 89% 81% 85% 81% 87% 83% 87% 89% 86% 86% 90% 85% 87% 80% 88% 85% 84% 77% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]8.7751187
GSM549102patient 115, normal, homogenized [OPG study]8.7754188
GSM549104patient 119, normal, homogenized [OPG study]8.3080483
GSM549108patient 138, normal, homogenized [OPG study]8.43986
GSM549119patient 077, normal, homogenized [OPG study]9.2691190
GSM549133patient 032, cancer, homogenized [OPG study]8.1281681
GSM549139patient 042, cancer, homogenized [OPG study]8.7793987
GSM549099patient 107, normal, homogenized [OPG study]8.626687
GSM549109patient 139, normal, homogenized [OPG study]8.5550386
GSM549110patient 046, normal, homogenized [OPG study]9.1562889
GSM549114patient 063, normal, homogenized [OPG study]9.5241291
GSM549122patient 082, normal, homogenized [OPG study]8.831688
GSM549134patient 033, cancer, homogenized [OPG study]8.519985
GSM549136patient 036, cancer, homogenized [OPG study]8.1892682
GSM549140patient 044, cancer, homogenized [OPG study]8.3712984
GSM549111patient 047, normal, homogenized [OPG study]9.0095688
GSM549113patient 057, normal, homogenized [OPG study]9.2717789
GSM549132patient 031, cancer, homogenized [OPG study]8.8659488
GSM549137patient 038, cancer, homogenized [OPG study]7.9367380
GSM549142patient 047, cancer, homogenized [OPG study]7.490779
GSM549100patient 110, normal, homogenized [OPG study]8.5760886
GSM549107patient 135, normal, homogenized [OPG study]8.7659887
GSM549115patient 068, normal, homogenized [OPG study]9.0701688
GSM549116patient 072, normal, homogenized [OPG study]8.775287
GSM549120patient 078, normal, homogenized [OPG study]9.1256489
GSM549131patient 030, cancer, homogenized [OPG study]8.72886
GSM549118patient 074, normal, homogenized [OPG study]9.1355789
GSM549129patient 027, cancer, homogenized [OPG study]7.9485981
GSM549123patient 088, normal, homogenized [OPG study]8.502485
GSM549124patient 006, cancer, homogenized [OPG study]7.9189581
GSM549126patient 015, cancer, homogenized [OPG study]8.7619687
GSM549128patient 025, cancer, homogenized [OPG study]8.3107983
GSM549103patient 117, normal, homogenized [OPG study]8.6284287
GSM549117patient 073, normal, homogenized [OPG study]9.1967689
GSM549138patient 041, cancer, homogenized [OPG study]8.5634786
GSM549141patient 045, cancer, homogenized [OPG study]8.7349986
GSM549130patient 028, cancer, homogenized [OPG study]9.1149590
GSM549101patient 111, normal, homogenized [OPG study]8.469485
GSM549105patient 128, normal, homogenized [OPG study]8.6307187
GSM549106patient 134, normal, homogenized [OPG study]8.0788280
GSM549112patient 048, normal, homogenized [OPG study]8.9998988
GSM549125patient 011, cancer, homogenized [OPG study]8.4007285
GSM549127patient 024, cancer, homogenized [OPG study]8.3602884
GSM549135patient 035, cancer, homogenized [OPG study]7.6511477